ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Icatibant Acetate Injection shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2026-05-07 · last update 2026-05-07

Manufacturers: Fresenius Kabi USA, LLC

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-86)Fresenius Kabi USA, LLCTo Be Discontinued
 —Discontinuation of the manufacturer of the drugPosted 05/07/2026
Updated 05/07/2026
Discontinued 05/07/2026
Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-93)Fresenius Kabi USA, LLCTo Be Discontinued
 —Discontinuation of the manufacturer of the drugPosted 05/07/2026
Updated 05/07/2026
Discontinued 05/07/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)